SILVERARC CAPITAL MANAGEMENT, LLC
CIK 1816307 · Holdings on Mar 31, 2024 · First reported May 15, 2024
Top ten holdings
Q1 2024- MRUS7.15%
- SLDB4.95%
- MORF4.78%
- ORIC4.29%
- 59045L1063.73%
- CLDX3.52%
- RNA3.50%
- NUVL3.32%
- CCCC3.29%
- PRAX3.26%
Share classes counted separately41.79%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- SLDBWeight increased · +3.82 pp1.13% → 4.95%Shares +730.21K (+122.75%)
- MGNXWeight decreased · -1.76 pp3.73% → 1.97%Shares -780.56K (-62.02%)
- MRUSWeight increased · +1.67 pp5.48% → 7.15%Shares -79.29K (-12.28%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 26
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | MRUSMERUS NV View history and evidence | $25.50M | 7.15% | 566.29K shares | 5.48% → 7.15%+1.67 pp -79.29K (-12.28%) | Reduced | ↗▾ |
| 02 | SLDBSOLID BIOSCIENCES INCCOM NEW View history and evidence | $17.65M | 4.95% | 1.33M shares | 1.13% → 4.95%+3.82 pp +730.21K (+122.75%) | Added | ↗▾ |
| 03 | MORFMORPHIC HOLDING INC View history and evidence | $17.04M | 4.78% | 483.97K shares | 4.45% → 4.78%+0.33 pp -16.07K (-3.21%) | Reduced | ↗▾ |
| 04 | ORICORIC PHARMACEUTICALS INC View history and evidence | $15.30M | 4.29% | 1.11M shares | 3.32% → 4.29%+0.97 pp -56.99K (-4.87%) | Reduced | ↗▾ |
| 05 | 59045L106MERSANA THERAPEUTICS INC View history and evidence | $13.30M | 3.73% | 2.97M shares | 4.59% → 3.73%-0.86 pp -3.45M (-53.76%) | Reduced | ↗▾ |
| 06 | CLDXCELLDEX THERAPEUTICS INCCOM NEW View history and evidence | $12.56M | 3.52% | 299.32K shares | 3.02% → 3.52%+0.50 pp +52.10K (+21.08%) | Added | ↗▾ |
| 07 | RNAAVIDITY BIOSCIENCES INC View history and evidence | $12.49M | 3.50% | 489.30K shares | Prior unavailable +489.30K | New | ↗▾ |
| 08 | NUVLNUVALENT INC-A View history and evidence | $11.85M | 3.32% | 157.75K shares | 4.38% → 3.32%-1.06 pp -35.25K (-18.26%) | Reduced | ↗▾ |
| 09 | CCCCC4 THERAPEUTICS INCCOM STK View history and evidence | $11.73M | 3.29% | 1.44M shares | Prior unavailable +1.44M | New | ↗▾ |
| 10 | PRAXPRAXIS PRECISION MEDICINES ICOM NEW View history and evidence | $11.63M | 3.26% | 190.56K shares | 1.95% → 3.26%+1.31 pp -93.28K (-32.87%) | Reduced | ↗▾ |
Options overlay 4
$3.43M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
MGNXMACROGENICS INCCALL View history and evidence | Call | 145.50K | $2.14M | +145.50K | ▾ |
CCCCC4 THERAPEUTICS INCCALL View history and evidence | Call | 150.00K | $1.23M | +150.00K | ▾ |
AMLXAMYLYX PHARMACEUTICALS INCCALL View history and evidence | Call | 20.00K | $56.80K | +20.00K | ▾ |
3 / 4 options · preview only
Exited positions 24
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| MDT MEDTRONIC PLC | Non-derivative | -135,000 | -$11.12M | SEC filing ↗ | SEC filing ↗ |
| SNY SANOFI-ADR | Non-derivative | -220,000 | -$10.94M | SEC filing ↗ | SEC filing ↗ |
| MRTX MIRATI THERAPEUTICS INC | Call | -150,000 | -$8.81M | SEC filing ↗ | SEC filing ↗ |
3 / 24 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1816307 · Period 2024-03-31
Data loaded 2026-09-23 · First reported 2024-05-15
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 360052733
}Research all 77 reported holdings.
This page includes 30 of 77 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 77 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1816307","quarter":"2024Q1","page_size":100}
get_institutional_manager_history
{"cik":"1816307","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.